Bill

Bill > S4011


US S4011

US S4011
Capping Drug Costs for Seniors Act of 2022


summary

Introduced
04/06/2022
In Committee
04/06/2022
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To amend title XVIII of the Social Security Act to provide for a cap on beneficiary liability under part D of the Medicare program, and for other purposes.

AI Summary

This bill proposes to amend Medicare Part D to provide a cap on beneficiary liability, with key provisions including: - Redesigning the Part D benefit structure by setting the annual out-of-pocket threshold at $2,000 for 2025 and increasing it annually thereafter, and adjusting the reinsurance payment amount to be 20-40% of costs above the out-of-pocket threshold depending on whether the drugs are "applicable drugs" subject to the new manufacturer discount program. - Establishing a new "Manufacturer Discount Program" starting in 2025 that requires drug manufacturers to provide discounts of 80-90% on applicable drugs for beneficiaries who have not yet reached the out-of-pocket threshold. - Phasing out the existing Medicare Coverage Gap Discount Program after 2024. - Making various conforming amendments to other Medicare Part D provisions to align with the new benefit structure and manufacturer discount program. The overall goal of the bill is to provide financial relief for Medicare Part D beneficiaries, particularly seniors, by capping their out-of-pocket drug costs and requiring deeper discounts from manufacturers.

Committee Categories

Budget and Finance

Sponsors (1)

Last Action

Read twice and referred to the Committee on Finance. (on 04/06/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...